Literature DB >> 3017131

Cardiac function and chronotropic sensitivity to beta-adrenergic stimulation in sepsis.

L W Smith, S L Winbery, L A Barker, K H McDonough.   

Abstract

An organism's cardiovascular response to sepsis is at least partly dependent on hormonal and neural modulation of myocardial function. We have investigated both intrinsic myocardial performance and one aspect of myocardial sensitivity to beta-adrenergic stimulation in a model of sepsis in which animals, at the time studied, exhibited bacteremia, normal arterial blood pressure and cardiac output, elevated heart rate, and elevated plasma catecholamines. Intrinsic myocardial contractile function, studied with the isolated, perfused working heart preparation, was depressed over a range of preloads in septic animals, whereas heart rate was elevated. To determine whether hearts from septic animals could respond normally to beta-adrenergic stimulation, we studied chronotropic responses to isoproterenol in both Langendorff perfused hearts and in isolated right atria. In langendorff perfused hearts from septic animals, basal rates were significantly increased and lower concentrations of isoproterenol elicited greater increases in heart rate. In isolated right atria from septic animals, basal rates were also elevated and the EC50 for the chronotropic response to isoproterenol was significantly less than in atria from control animals. The maximal heart rate response to isoproterenol was not significantly different from control. These results indicate that in sepsis, despite apparently adequate in vivo cardiac performance, intrinsic myocardial function is depressed, but chronotropic sensitivity to beta-adrenergic stimulation is increased.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3017131     DOI: 10.1152/ajpheart.1986.251.2.H405

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  1 in total

1.  Oroxylin a, but not vasopressin, ameliorates cardiac dysfunction of endotoxemic rats.

Authors:  Chin-Hung Liu; Mei-Fang Chen; Tzu-Ling Tseng; Lih-Geeng Chen; Jon-Son Kuo; Tony Jer-Fu Lee
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-24       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.